Merck to focus on cancer immunotherapy, multiple sclerosis and infertility

Published: 2018-06-28 16:29:00
Updated: 2018-06-28 16:28:38

Merck Korea, a Korean branch of Merch, the global life science company, announced a promise to lead the future industry by focusing on ‘cancer immunotherapy,’ ‘multiple sclerosis’ and ‘infertility’ in the pharmaceutical field.

On the 26th, Merck Korea held a press conference to celebrate the 350...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.